WA
BIOR

WealthTrust Axiom’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

WealthTrust Axiom’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40
Closed -$32.9K – 263
2022
Q4 		$32.9K Hold
40
– – 0.01% 238
2022
Q3 		$4K Hold
40
– – ﹤0.01% 245
2022
Q2 		$7K Hold
40
– – ﹤0.01% 247
2022
Q1 		$11K Hold
40
– – ﹤0.01% 265
2021
Q4 		$20K Buy
+40
New +$28.7K 0.01% 263

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

WealthTrust Axiom's BIOR Position: Q1 2023 in Review

WealthTrust Axiom sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2023, closing a stake of 40 shares — an estimated $32.9K sold.

WealthTrust Axiom first reported a position in BIOR in Q4 2021 and held it in 5 quarters. The position peaked at $32.9K in Q4 2022. 30 funds tracked by Wall St. Rank hold BIOR as of Q1 2023.

  • WealthTrust Axiom reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • WealthTrust Axiom sold 40 Biora Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $32.9K.
  • WealthTrust Axiom first reported a position in Biora Therapeutics, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • WealthTrust Axiom's Biora Therapeutics, Inc. Common Stock position peaked at $32.9K in Q4 2022.
  • 30 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2023.

Based on WealthTrust Axiom's 13F filing for Q1 2023, filed 3 May 2023.